Investigators sought to determine the frequency of major depressive disorder in patients in epilepsy clinics.
Multimarker inflammatory biosignatures are expected to facilitate diagnosis and predict treatment outcomes for various central nervous system disorders, particularly Alzheimer disease and major depressive disorder.
A study evaluated the long-term adverse effects of maternal depression on child development.
Greater depressive symptoms are associated with episodic memory and markers of brain aging in older Caribbean Hispanic patients.
Lundbeck announced that the FDA has approved a sNDA for Trintellix to include data regarding improved processing speed.
AAN 2018 Coverage
Researchers sought to assess outcomes in hospitalized patients with comorbid Parkinson disease and major depressive disorder following administration of deep brain stimulation.
For patients with major depressive disorde, relapse is associated with brain cortical changes over two years.
For adults with bipolar depression, tDCS seems to be safe and effective as an add-on intervention.
The FDA has cleared Nexstim's NBT system for the treatment of major depressive disorder.
Most patients undergoing skull base irradiation for cancer do not have detectable cognitive impairment.